These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 33417957)

  • 1. Hyperglycemic levels in early stage of diabetic nephropathy affect differentially renal expression of claudins-2 and -5 by oxidative stress.
    Rosas-Martínez L; Rodríguez-Muñoz R; Namorado-Tonix MDC; Missirlis F; Del Valle-Mondragón L; Sánchez-Mendoza A; Reyes-Sánchez JL; Cervantes-Pérez LG
    Life Sci; 2021 Mar; 268():119003. PubMed ID: 33417957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxidative stress induces claudin-2 nitration in experimental type 1 diabetic nephropathy.
    Molina-Jijón E; Rodríguez-Muñoz R; Namorado Mdel C; Pedraza-Chaverri J; Reyes JL
    Free Radic Biol Med; 2014 Jul; 72():162-75. PubMed ID: 24726862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aldosterone signaling regulates the over-expression of claudin-4 and -8 at the distal nephron from type 1 diabetic rats.
    Molina-Jijón E; Rodríguez-Muñoz R; González-Ramírez R; Namorado-Tónix C; Pedraza-Chaverri J; Reyes JL
    PLoS One; 2017; 12(5):e0177362. PubMed ID: 28493961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N-acetylcysteine protects against diabetic nephropathy through control of oxidative and nitrosative stress by recovery of nitric oxide in rats.
    Nogueira GB; Punaro GR; Oliveira CS; Maciel FR; Fernandes TO; Lima DY; Rodrigues AM; Mouro MG; Araujo SRR; Higa EMS
    Nitric Oxide; 2018 Aug; 78():22-31. PubMed ID: 29778909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperglycemia causes cellular senescence via a SGLT2- and p21-dependent pathway in proximal tubules in the early stage of diabetic nephropathy.
    Kitada K; Nakano D; Ohsaki H; Hitomi H; Minamino T; Yatabe J; Felder RA; Mori H; Masaki T; Kobori H; Nishiyama A
    J Diabetes Complications; 2014; 28(5):604-11. PubMed ID: 24996978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of oxidative stress in streptozotocin-induced diabetic nephropathy in rats.
    Fernandes SM; Cordeiro PM; Watanabe M; Fonseca CD; Vattimo MF
    Arch Endocrinol Metab; 2016 Oct; 60(5):443-449. PubMed ID: 27812607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diphenyl diselenide ameliorates diabetic nephropathy in streptozotocin-induced diabetic rats via suppressing oxidative stress and inflammation.
    Wang X; Li C; Huan Y; Cao H; Sun S; Lei L; Liu Q; Liu S; Ji W; Huang K; Shen Z; Zhou J
    Chem Biol Interact; 2021 Apr; 338():109427. PubMed ID: 33639173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renoprotective effects of berberine through regulation of the MMPs/TIMPs system in streptozocin-induced diabetic nephropathy in rats.
    Ni WJ; Ding HH; Zhou H; Qiu YY; Tang LQ
    Eur J Pharmacol; 2015 Oct; 764():448-456. PubMed ID: 26192633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Zinc supplementation alleviates the progression of diabetic nephropathy by inhibiting the overexpression of oxidative-stress-mediated molecular markers in streptozotocin-induced experimental rats.
    Barman S; Pradeep SR; Srinivasan K
    J Nutr Biochem; 2018 Apr; 54():113-129. PubMed ID: 29331868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BAY 11-7082 ameliorates diabetic nephropathy by attenuating hyperglycemia-mediated oxidative stress and renal inflammation via NF-κB pathway.
    Kolati SR; Kasala ER; Bodduluru LN; Mahareddy JR; Uppulapu SK; Gogoi R; Barua CC; Lahkar M
    Environ Toxicol Pharmacol; 2015 Mar; 39(2):690-9. PubMed ID: 25704036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of benazepril on renal function and kidney expression of matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 in diabetic rats.
    Sun SZ; Wang Y; Li Q; Tian YJ; Liu MH; Yu YH
    Chin Med J (Engl); 2006 May; 119(10):814-21. PubMed ID: 16732983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of Sodium-Glucose Co-Transporter 2 Inhibitor, Dapagliflozin, on Renal Renin-Angiotensin System in an Animal Model of Type 2 Diabetes.
    Shin SJ; Chung S; Kim SJ; Lee EM; Yoo YH; Kim JW; Ahn YB; Kim ES; Moon SD; Kim MJ; Ko SH
    PLoS One; 2016; 11(11):e0165703. PubMed ID: 27802313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kidney involvement in a nongenetic rat model of type 2 diabetes.
    Danda RS; Habiba NM; Rincon-Choles H; Bhandari BK; Barnes JL; Abboud HE; Pergola PE
    Kidney Int; 2005 Dec; 68(6):2562-71. PubMed ID: 16316331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The combined strategy with PPARα agonism and AT₁ receptor antagonism is not superior relative to their individual treatment approach in preventing the induction of nephropathy in the diabetic rat.
    Bishnoi HK; Mahadevan N; Balakumar P
    Pharmacol Res; 2012 Oct; 66(4):349-56. PubMed ID: 22796657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simvastatin ameliorates diabetic nephropathy by attenuating oxidative stress and apoptosis in a rat model of streptozotocin-induced type 1 diabetes.
    Al-Rasheed NM; Al-Rasheed NM; Bassiouni YA; Hasan IH; Al-Amin MA; Al-Ajmi HN; Mahmoud AM
    Biomed Pharmacother; 2018 Sep; 105():290-298. PubMed ID: 29860221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kidney expression of glutathione peroxidase-1 is not protective against streptozotocin-induced diabetic nephropathy.
    de Haan JB; Stefanovic N; Nikolic-Paterson D; Scurr LL; Croft KD; Mori TA; Hertzog P; Kola I; Atkins RC; Tesch GH
    Am J Physiol Renal Physiol; 2005 Sep; 289(3):F544-51. PubMed ID: 15827346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PARP inhibition ameliorates nephropathy in an animal model of type 2 diabetes: focus on oxidative stress, inflammation, and fibrosis.
    Zakaria EM; El-Maraghy NN; Ahmed AF; Ali AA; El-Bassossy HM
    Naunyn Schmiedebergs Arch Pharmacol; 2017 Jun; 390(6):621-631. PubMed ID: 28224182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kefir administration reduced progression of renal injury in STZ-diabetic rats by lowering oxidative stress.
    Punaro GR; Maciel FR; Rodrigues AM; Rogero MM; Bogsan CS; Oliveira MN; Ihara SS; Araujo SR; Sanches TR; Andrade LC; Higa EM
    Nitric Oxide; 2014 Feb; 37():53-60. PubMed ID: 24406684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lumbrokinase attenuates diabetic nephropathy through regulating extracellular matrix degradation in Streptozotocin-induced diabetic rats.
    Sun H; Ge N; Shao M; Cheng X; Li Y; Li S; Shen J
    Diabetes Res Clin Pract; 2013 Apr; 100(1):85-95. PubMed ID: 23384615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of renal tubule-specific knockdown of the Na
    Onishi A; Fu Y; Darshi M; Crespo-Masip M; Huang W; Song P; Patel R; Kim YC; Nespoux J; Freeman B; Soleimani M; Thomson S; Sharma K; Vallon V
    Am J Physiol Renal Physiol; 2019 Aug; 317(2):F419-F434. PubMed ID: 31166707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.